Home › Generalized Anxiety Disorder › Florida › Miami
Generalized Anxiety Disorder clinical trials in Miami, FL
5 studies for Generalized Anxiety Disorder are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
RecruitingPhase 2
- Miami Dade Medical Research Institute, Miami
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
RecruitingPhase 3
- Sunshine Medical Research Studies Inc, Miami
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
RecruitingPhase 2
- Premier Clinical Research, Miami
- Global Medical Institutes, Miami
- Miami Dade Medical Research Institute, Miami
- and 1 more
A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment
RecruitingPhase 3
- Nuovida Research Center, Miami
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
RecruitingPhase 2
- GMI Florida - Central Miami Medical Institute /ID# 267839, Miami
- Allied Biomedical Res Inst Inc /ID# 267813, Miami
Generalized Anxiety Disorder trials in other cities
- Philadelphia, PA7 studies
- Los Angeles, CA6 studies
- New York City, NY6 studies
- Austin, TX5 studies
- Boston, MA5 studies
- Oklahoma City, OK4 studies
- Orlando, FL4 studies
- Brooklyn, NY4 studies
- San Bernardino, CA3 studies
- Burbank, CA3 studies
- Chicago, IL3 studies
- Columbus, OH3 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Prostate Cancer30 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.